Snake poisoning case study in short brief based on real case
real case study snake envenomation clinical presentation treatment antivenom
"snake envenomation" AND "case report" AND antivenom
PMID: 38379491
| Day | Intervention | Response |
|---|---|---|
| Days 1-3 | 16 packs plasma + 40 total antivenom vials (VACSERA polyvalent) | Hemoglobin fell, platelets dropped, jaundice appeared |
| Day 3 | LDH = 520, reticulocytes 3.5%, PT >300s, INR still unmeasurable | Antivenom-unresponsive coagulopathy |
| Day 4-5 | Plasmapheresis + corticosteroids added | Marked improvement in PT, PC, INR |
| Day 6 | Discharged | Full clinical recovery |
| Grade | Features |
|---|---|
| Dry bite (~25% cases) | Fang marks only, no systemic effects |
| Mild | Local pain, swelling, minor lab changes |
| Moderate | Progressive swelling, coagulopathy (elevated PT/INR, low fibrinogen) |
| Severe | Systemic collapse, hemorrhage, neurotoxicity, organ failure |
| Feature | Viperid (Viper/Pit Viper) | Elapid (Cobra/Krait/Coral) |
|---|---|---|
| Main toxicity | Hemotoxic, cytotoxic | Neurotoxic |
| Local tissue | Marked swelling, necrosis | Minimal swelling |
| Onset | Rapid local effects | Delayed neurologic (15-30 min) |
| Key danger | Coagulopathy, organ failure | Respiratory paralysis |